Interstitial Lung Disease Trial, Recruiting NCT06182748 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Recruiting

NCT06182748
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have a scarring/stiffening lung disease (called fibrosing PID) where more than 10% of the lung tissue shows scarring on a chest CT scan
  • People who are able to attend a physical fitness/exercise program three times per week
  • People who are enrolled in a health insurance scheme
  • People who are willing and able to sign a consent form agreeing to participate

Who may not be able to join:

  • People who have a medical reason that prevents them from doing physical activity (as defined by French Society of Cardiology guidelines from 2018 — confirm with trial site)
  • People who are unable to exercise on a stationary bike or treadmill
  • People who are unable to complete an exercise stress test, including those who use oxygen at home while resting
  • People whose lung disease is currently in a flare-up (active worsening episode)
  • People who have had a change in their treatment within the last 3 months
  • People who have a condition called sarcoidosis
  • People who have a connective tissue disease (a condition affecting joints, skin, or organs — confirm with trial site)
  • People who are currently pregnant
  • People who are already participating in another treatment research study
  • People who are under legal guardianship
  • People who are subject to any other legal protection measure
  • People who receive state medical aid (a specific government-funded healthcare assistance program — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 November 2023
Est. completion
2 March 2024

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Maximal oxygen uptake (VO2pic) during maximal cardiopulmonary exercise testing on ergocycle

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov